The ABC of protein kinase conformations

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1854, Issue 10, 2015, Pages 1555-1566

  Möbitz, Henrik ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Active, C out DFG out conformation; Classification; Kinase inhibitor; Protein kinase; Universal kinase residue nomenclature

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; PROTEIN KINASE; PROTEIN BINDING; PROTEIN KINASE INHIBITOR;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; ENZYME ACTIVITY; ENZYME CONFORMATION; MECHANICAL TORSION; NOMENCLATURE; PRIORITY JOURNAL; PROTEIN DATA BANK; PROTEIN DOMAIN; PROTEIN MOTIF; REVIEW; ANIMAL; CHEMISTRY; GENETICS; HUMAN; PROTEIN CONFORMATION; PROTEIN DATABASE; THERMODYNAMICS;

AMINO ACID MOTIFS; ANIMALS; DATABASES, PROTEIN; HUMANS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; THERMODYNAMICS;

EID: 84941803293     PISSN: 15709639     EISSN: 18781454     Source Type: Journal    
DOI: 10.1016/j.bbapap.2015.03.009     Document Type: Review

References (49)

1. G. Manning, D.B. Whyte, R. Martinez, T. Hunter, and S. Sudarsanam The protein kinase complement of the human genome Science 298 2002 1912 1934
2. P. Cohen Protein kinases - the major drug targets of the twenty-first century? Nat. Rev. Drug Discov. 1 2002 309 315
3. C.H. Yun, and et al. The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP Proc. Natl. Acad. Sci. U. S. A. 105 2008 2070 2075
4. M. Azam, M.A. Seeliger, N.S. Gray, J. Kuriyan, and G.Q. Daley Activation of tyrosine kinases by mutation of the gatekeeper threonine Nat. Struct. Mol. Biol. 15 2008 1109 1118
5. M.J. Eck, and C.H. Yun Structural and mechanistic underpinnings of the differential drug sensitivity of EGFR mutations in non-small cell lung cancer Biochim. Biophys. Acta 559-566 1804
6. T. Okuzumi, and et al. Inhibitor hijacking of Akt activation Nat. Chem. Biol. 5 2009 484 493
7. Hatzivassiliou, G. et al. RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth. Nature 464, 431-435.
8. Poulikakos, P.I., Zhang, C., Bollag, G., Shokat, K.M. & Rosen, N. RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF. Nature 464, 427-430.
9. J. Zheng, and et al. 2.2 A refined crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MnATP and a peptide inhibitor Acta Crystallogr. D Biol. Crystallogr. 49 1993 362 365
10. D.R. Knighton, and et al. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase Science 253 1991 407 414
11. Madhusudan, P. Akamine, N.H. Xuong, and S.S. Taylor Crystal structure of a transition state mimic of the catalytic subunit of cAMP-dependent protein kinase Nat. Struct. Biol. 9 2002 273 277
12. M. Huse, and J. Kuriyan The conformational plasticity of protein kinases Cell 109 2002 275 282
13. P. Traxler, and P. Furet Strategies toward the design of novel and selective protein tyrosine kinase inhibitors Pharmacol. Ther. 82 1999 195 206
14. Y. Liu, and N.S. Gray Rational design of inhibitors that bind to inactive kinase conformations Nat. Chem. Biol. 2 2006 358 364
15. B. Li, Y. Liu, T. Uno, and N. Gray Creating chemical diversity to target protein kinases Comb. Chem. High Throughput Screen. 7 2004 453 472
16. A.K. Ghose, T. Herbertz, D.A. Pippin, J.M. Salvino, and J.P. Mallamo Knowledge based prediction of ligand binding modes and rational inhibitor design for kinase drug discovery J. Med. Chem. 51 2008 5149 5171
17. F. Zuccotto, E. Ardini, E. Casale, and M. Angiolini Through the "gatekeeper door": exploiting the active kinase conformation J. Med. Chem. 53 2010 2681 2894
18. M.D. Jacobs, P.R. Caron, and B.J. Hare Classifying protein kinase structures guides use of ligand-selectivity profiles to predict inactive conformations: structure of lck/imatinib complex Proteins 70 2008 1451 1460
19. N. Brooijmans, Y.W. Chang, D. Mobilio, R.A. Denny, and C. Humblet An enriched structural kinase database to enable kinome-wide structure-based analyses and drug discovery Protein Sci. 19 2010 763 774
20. A.C. Backes, B. Zech, B. Felber, B. Klebl, and G. Müller Small-molecule inhibitors binding to protein kinase Part II: the novel pharmacophore approach of type II and type III inhibition Expert Opin. Drug Discov. 3 2008 1427 1449
21. T. Naumann, and H. Matter Structural classification of protein kinases using 3D molecular interaction field analysis of their ligand binding sites: target family landscapes J. Med. Chem. 45 2002 2366 2378
22. S.L. Kinnings, and R.M. Jackson Binding site similarity analysis for the functional classification of the protein kinase family J. Chem. Inf. Model. 49 2009 318 329
23. D. Kuhn, N. Weskamp, E. Hullermeier, and G. Klebe Functional classification of protein kinase binding sites using Cavbase ChemMedChem 2 2007 1432 1447
24. L. Sawyer, and et al. The atomic structure of crystalline porcine pancreatic elastase at 2.5 A resolution: comparisons with the structure of alpha-chymotrypsin J. Mol. Biol. 118 1978 137 208
25. R. Huber, and et al. Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. II. Crystallographic refinement at 1.9 A resolution J. Mol. Biol. 89 1974 73 101
26. S.W. Cowan-Jacob, and et al. Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia Acta Crystallogr. D Biol. Crystallogr. 63 2007 80 93
27. B. Nolen, S. Taylor, and G. Ghosh Regulation of protein kinases; controlling activity through activation segment conformation Mol. Cell 15 2004 661 675
28. N. Katayama, and et al. Identification of a key element for hydrogen-bonding patterns between protein kinases and their inhibitors Proteins 73 2008 795 801
29. Z. Wang, and et al. Structural basis of inhibitor selectivity in MAP kinases Structure 6 1998 1117 1128
30. B. Nagar, and et al. Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571) Cancer Res. 62 2002 4236 4243
31. A.P. Kornev, N.M. Haste, S.S. Taylor, and L.F. Eyck Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism Proc. Natl. Acad. Sci. U. S. A. 103 2006 17783 17788
32. P.D. Jeffrey, and et al. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex Nature 376 1995 313 320
33. H.L. De Bondt, and et al. Crystal structure of cyclin-dependent kinase 2 Nature 363 1993 595 602
34. N.M. Levinson, and et al. A Src-like inactive conformation in the abl tyrosine kinase domain PLoS Biol. 4 2006 e144
35. Y. Shan, and et al. A conserved protonation-dependent switch controls drug binding in the Abl kinase Proc. Natl. Acad. Sci. U. S. A. 106 2009 139 144
36. T. Fox, and et al. A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase Protein Sci. 7 1998 2249 2255
37. A.P. Kornev, S.S. Taylor, and L.F. Ten Eyck A helix scaffold for the assembly of active protein kinases Proc. Natl. Acad. Sci. U. S. A. 105 2008 14377 14382
38. N. Kannan, A.F. Neuwald, and S.S. Taylor Analogous regulatory sites within the alphaC-beta4 loop regions of ZAP-70 tyrosine kinase and AGC kinases Biochim. Biophys. Acta 1784 2008 27 32
39. C.M. Emery, and et al. MEK1 mutations confer resistance to MEK and B-RAF inhibition Proc. Natl. Acad. Sci. U. S. A. 106 2009 20411 20416
40. Vajpai, N. et al. Solution conformations and dynamics of ABL kinase-inhibitor complexes determined by NMR substantiate the different binding modes of imatinib/nilotinib and dasatinib. J Biol Chem 283, 18292-18302. DOI: http://dx.doi.org/10.1074/jbc.M801337200.
41. I. Kufareva, and R. Abagyan Type-II kinase inhibitor docking, screening, and profiling using modified structures of active kinase states J. Med. Chem. 51 2008 7921 7932
42. S. Favelyukis, J.H. Till, S.R. Hubbard, and W.T. Miller Structure and autoregulation of the insulin-like growth factor 1 receptor kinase Nat. Struct. Biol. 8 2001 1058 1063
43. S.R. Hubbard Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog EMBO J. 16 1997 5572 5581
44. G.N. Ramachandran, C. Ramakrishnan, and V. Sasisekharan Stereochemistry of polypeptide chain configurations J. Mol. Biol. 7 1963 95 99
45. The PyMOL Molecular Graphics System, Version 1.5.0.4 Schrödinger, LLC.
46. R.P. Joosten, and et al. PDB-REDO: automated re-refinement of X-ray structure models in the PDB J. Appl. Crystallogr. 42 2009 376 384 (URL: http://www.cmbi.ru.nl/pdb-redo/)
47. M. Levitt, and A. Warshel Computer simulation of protein folding Nature 253 1975 694 698
48. K. Oruganty, N.S. Talathi, Z.A. Wood, and N. Kannan Identification of a hidden strain switch provides clues to an ancient structural mechanism in protein kinases Proc. Natl. Acad. Sci. U. S. A. 110 2013 924 929
49. P. Schmidtke, F.J. Luque, J.B. Murray, and X. Barril Shielded hydrogen bonds as structural determinants of binding kinetics: application in drug design J. Am. Chem. Soc. 133 2011 18903 18910